Mixed-type Early Gastric Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Mixed-type Early Gastric Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07012447

Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations

The goal of this clinical trial is to evaluate the efficacy and safety of venetoclax combined with azacitidine in treating newly diagnosed early T-cell precurso…

China32 participantsStarted 2025-04-01

Treatment: Venetoclax, Azacitidine

All recent trials (2 shown)

CompletedNot Applicable

NCT07096947

A Multifactor Prediction Model for Non-curative Outcomes in Mixed-type Early Gastric Cancer

The goal of this dual-center study is to identify the most valuable predictive factors (MVPs) for non-curable mixed-type early gastric cancer (NC-MTEGC) and dev…

China421 participantsStarted 2017-01-18